OA: Case Report - Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancer Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, November 23, 2016

OA: Case Report - Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancer



open access

To our knowledge this Is only the third report in the literature demonstrating that Sunitinib monotherapy can provoke a response in chemotherapy refractory clear cell ovarian cancer.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.